View Older Stories View More Recent Stories
-
Barclays maintains an 'Underweight' on Walgreen (WAG); 1Q12 Earnings Preview
-
Walgreens First Quarter 2012 Earnings Release, Conference Call Dec. 21
-
Pre-Open Movers 11/9: (SODA) (KITD) (PANL) Higher; (ROVI) (MFB) (ADBE) Lower (more...)
-
Jefferies Raises Price Target on CVS Caremark (CVS), Sees Upside Potential
-
Premier Beverage Group Announces Captive Brands Strategy
-
Barclays Maintains an 'Underweight' on Walgreen (WAG); Current Earnings Don't Matter
-
Jefferies Cuts Price Target on Walgreen (WAG), Encourges a Settlement with Express Scripts (ESRX)
-
Walgreen (WAG) Shares Head Lower as Raymond James Cuts to Market Perform in Mid-Day Note
-
Highlights From WAG's Q4 Conference Call: Substantial Progress on Our Transformation Strategy
-
Walgreen (WAG) Slumps Amid Q4 Beat: CFO Says No Express Scripts (ESRX) Contract Will Be Negative to Earnings
-
Pre-Open Movers 9/27: (MCP) (SLV) (RENN) Higher; (KEYW) (ACW) (NDN) Lower (more...)
-
Walgreen (WAG) Tops Q4 Views; No Express Scripts Resolution Yet
-
Q4 Preview: Walgreen (WAG) Investors Looking for Express Scripts, Generic Drug Updates
-
Jim Cramer Lists Catalysts for the Week
-
Deutsche Bank Starts Walgreen (WAG) at Hold, Sets Price Target at $38.50
-
Barclays Maintains an 'Underweight' on Walgreen (WAG); 4Q11 Earnings Preview
-
Jefferies Comments on Express Scripts (ESRX), Great Long-Term Pick for Investors
-
Leerink Swann Maintains an 'Outperform' on Express Scripts (ESRX); Merger Timing, Script Trends, Walgreen and Valuation
-
UPDATE - Barclays Downgraded Walgreen (WAG) to Underweight; Cutting Estimates & PT
-
Corporations Putting Cash to Use as Stocks Near 11-Month Low
-
Q2 Preview: CVS (CVS) Looking to PBM to Continue Strong Results
-
Barclays Maintains an 'Equalweight' on Walgreen (WAG); Drawing a Line in the Sand
-
Pre-Open Movers 6/21: (TOBC) (BBY) (MDR) Higher; (WAG) (ESRX) (PSEC) Lower (more...)
-
Walgreen (WAG) Beats Q3 Views, Express Scripts (ESRX) Decision Weighs
-
Walgreen (WAG) Cuts Out Express Scripts (ESRX)
-
Trading Radar for 06/20: Walgreen (WAG), Barnes & Noble (BKS), Adobe (ADBE), Jabil Circuit (JBL) Report
-
Barclays Maintains an 'Equalweight' on Walgreen (WAG); 3Q11 Earnings Preview
-
Credit Suisse Lifts Price Target On Walgreen (WAG)
-
Q1 Preview: CVS (CVS) May Have Prescription for Beat on Aetna Contract
-
It's Time To Buy Walgreen (WAG) - Analyst
-
Notable Mergers and Acquisitions of the Day 03/24: (WAG)/(DSCM) (PXP) (PKI)
-
Walgreen (WAG) To Acquire Drugstore.com (DSCM) for $3.80/Share in Cash
-
Morgan Stanley Says Buy the Weakness in Walgreen (WAG) Shares
-
Goldman Sachs Keeps Top Rating On Walgreen (WAG) Despite Lackluster Q2
-
Investors Welcome An Uneventful Day
-
Highlights From WAG's Q2 Conference Call: Record Sales and Earnings Contributed to Third Consecutive Qtr of Double Digit EPS Growth
-
Notable ETF Movers of the Day 03/22: (USO) (UNG) (EWZ) Higher; (TAN) (XHB) (SPY) Lower
-
Walgreen (WAG) Q2 Profit Jumps 10%; Results In Line
-
Trading Radar for 03/22: Adobe (ADBE), Walgreen (WAG), Carnival (CCL), Discover Financial (DFS), Jabil Circuit (JBL) Report
-
Canaccord Genuity Morning Coffee on Walgreen (WAG) and Catalyst Health (CHSI): Breaking Up...Not So Hard To Do
-
Notable 52-Week Highs and Lows of the Day 02/28: (IPG) (MRX) (CDE) High; (XPRT) (EK) Low
-
Walgreen (WAG) Sees a Boost After Getting Top Rating at Goldman Sachs
-
Daily State of the Markets 01/04: And They're Off!
-
Notable 52-Week Highs and Lows of the Day 12/22: WAG, ARMH, JBL, MAT, NXPI High; CAK Low
-
Walgreen (WAG) Trades Strong as Q1 Numbers are Just What the Doctor Ordered
-
Trading Radar for 12/22: Walgreen (WAG), Bed Bath & Beyond (BBBY), Micron Tech (MU), Lindsay Corp. (LNN) Report
-
Q1 Preview: Walgreen (WAG) May See Flat Quarter as Comps Slow (CVS, WMT)
-
UPDATE - UBS Upgrades Walgreen (WAG) to Buy; Time to Unleash Higher Profitability?
-
Standpoint Research Downgrades Walgreen (WAG) to Hold
